Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site exfoliation, Vaccination site induration, Vaccination site pruritus
Clinical narrative: injection site was itchy; injection site was hard; injection site was peeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient received bnt162b2 (BNT162B2), on 27May2022 as dose 6 (booster), single (Lot number: FM7553) at the age of 52 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "concussions", start date: 2015 (unspecified if ongoing); "contusion", start date: 2015 (unspecified if ongoing); "She had an accident" (unspecified if ongoing); "torn rotator cuff" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: bnt162b2 (DOSE 1, Lot Number: EL0149), administration date: 05Jan2021, when the patient was 51-year-old, for COVID-19 immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling"; bnt162b2 (DOSE 2, Lot Number: PAA156051), administration date: 27Jan2021, when the patient was 51-year-old, for COVID-19 immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling"; bnt162b2 (DOSE 3 (BOOSTER), Lot Number: EL0140), administration date: 06Jun2021, when the patient was 51-year-old, for COVID-19 immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling"; bnt162b2 (DOSE 4 (BOOSTER), Lot Number: EL3249), administration date: 26Jan2022, when the patient was 52-year-old, for COVID-19 immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling"; Bnt162b2 (DOSE 5 (BOOSTER), Lot Number: 3014584), for COVID-19 immunization, reaction(s): "injection site was peeling", "injection site was hard", "injection site was itchy". The following information was reported: VACCINATION SITE PRURITUS (non-serious), outcome "recovered", described as "injection site was itchy"; VACCINATION SITE INDURATION (non-serious), outcome "recovered", described as "injection site was hard"; VACCINATION SITE EXFOLIATION (non-serious), outcome "recovered", described as "injection site was peeling". Therapeutic measures were taken as a result of vaccination site pruritus, vaccination site induration, vaccination site exfoliation.  Additional information: She had an accident and had a torn rotator cuff and she was getting different injections, which was she was in an ice storm and had concussions and contusions, this occurred in 2015. The patient whom took all of the Pfizer covid vaccines including the booster stated that when the injection site was healing it was itchy, hard, and she took a Tylenol. She had 7 Pfizer covid vaccines. She did not have adverse reactions, only when it was healing. Thought it was after all the covid vaccine doses she was given, where the injection site was itchy, hard, and peeling. It took about 3 or 4 days to recover after each dose of the covid vaccine. She did not pay attention to it. They told her to exercise and move her arm around. She was in a rehabilitative facility and did not get the doses from her doctor. She was hoping that they did not write down the flu shot on this vaccination card. She was given a flu shot and covid booster shot on the same date. Flu shot and covid shot were given in opposite arms. Unknown which dose she was referring to where she was given flu shot on the same date. Fourth dose Pfizer covid vaccine: 26Jan2021, Clarified multiple times since date is discrepant. She stated she thinks it was written incorrectly as 26Jan2021 and should have been written as 26Jan2022.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300299879 same patient/product/AE, different dose number;